Core Insights - Step Long Pharmaceutical celebrates its 32nd anniversary, emphasizing its commitment to clinical needs, theoretical breakthroughs, and digital technology integration [1][2] - The company has developed key cardiovascular products based on the "Brain-Heart Treatment" theory, which has been validated through extensive clinical and experimental research [1] - Step Long Pharmaceutical has introduced a comprehensive health product range for women, expanding its clinical solutions [1] Research and Development - The company integrates artificial intelligence and big data into its drug development and production processes, enhancing drug quality and industry efficiency [1] - A new model of "Traditional Chinese Medicine + AI" has been established, leading to the development of a Chinese medicine combination warning system that has provided over ten thousand safety alerts [1] Production and Quality Control - Step Long Pharmaceutical has achieved full-chain digital control from herbal planting to drug production, with advanced quality control systems in place [2] - The production line for Brain-Heart Capsules features a comprehensive quality control traceability system, while the packaging line for Stable Heart Granules has reached a high level of automation [2] Agricultural Collaboration - The company has built a digital platform for herbal planting with 350 nodes, ensuring quality control and collaborating with over 5,000 farmers, resulting in an average income increase of over 30% for farmers [2] Future Directions - Step Long Pharmaceutical aims to continue focusing on "modern traditional Chinese medicine, technological traditional Chinese medicine, and quality traditional Chinese medicine," promoting the integration of traditional Chinese medicine with high technology [2]